Peroxiredoxin 4 (PRDX4): Its critical in vivo roles in animal models of metabolic syndrome ranging from atherosclerosis to nonalcoholic fatty liver disease
Author:
Affiliation:
1. Department of Pathology and Laboratory Medicine; Kanazawa Medical University; Ishikawa Japan
2. Laboratory of Pathology; Hebei Cancer Institute; The Fourth Hospital of Hebei Medical University; Hebei China
Publisher
Wiley
Subject
General Medicine,Pathology and Forensic Medicine
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/pin.12634/fullpdf
Reference61 articles.
1. The oxidant stress hypothesis of atherogenesis;Iuliano;Lipids,2001
2. Mitochondrial catalase overexpression protects insulin-producing cells against toxicity of reactive oxygen species and proinflammatory cytokines;Gurgul;Diabetes,2004
3. Atherosclerosis: An inflammatory disease;Ross;N Engl J Med,1999
4. Inflammation in atherosclerosis;Libby;Nature,2002
5. Overexpression of peroxiredoxin 4 protects against high-dose streptozotocin-induced diabetes by suppressing oxidative stress and cytokines in transgenic mice;Ding;Antioxid Redox Signal,2010
Cited by 33 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Regulatory role of PDK1 via integrated gene analysis of mitochondria-immune response in periodontitis;Gene;2024-08
2. Discovery of Urea Derivatives of Celastrol as Selective Peroxiredoxin 1 Inhibitors against Colorectal Cancer Cells;Journal of Medicinal Chemistry;2024-04-29
3. Validation of the interaction between PRDX4 and TXNDC5 in gastric cancer and the significance of the PRDX4 gene in gastric cancer based on a data mining analysis;Translational Cancer Research;2024-01
4. The combination of the low immunohistochemical expression of peroxiredoxin 4 and perilipin 2 predicts longer survival in pancreatic ductal adenocarcinoma with peroxiredoxin 4 possibly playing a main role;HISTOL HISTOPATHOL;2023
5. A human liver organoid screening platform for DILI risk prediction;Journal of Hepatology;2023-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3